OTCMKTS:SMLR Semler Scientific (SMLR) Stock Forecast, Price & News $27.58 -0.46 (-1.64%) (As of 05:11 PM ET) Add Compare Share Share Today's Range$27.48▼$28.2850-Day Range$21.91▼$30.5852-Week Range$19.12▼$46.31Volume65,964 shsAverage Volume60,839 shsMarket Capitalization$188.92 millionP/E Ratio13.72Dividend YieldN/APrice Target$45.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest Semler Scientific MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside63.2% Upside$45.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.95Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.99 out of 5 stars 3.0 Analyst's Opinion Consensus RatingSemler Scientific has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $45.00, Semler Scientific has a forecasted upside of 63.2% from its current price of $27.58.Amount of Analyst CoverageSemler Scientific has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SMLR. Previous Next 0.0 Dividend Strength Dividend YieldSemler Scientific does not currently pay a dividend.Dividend GrowthSemler Scientific does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SMLR. Previous Next 2.8 News and Social Media Coverage News SentimentSemler Scientific has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Semler Scientific this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for SMLR on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Semler Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders13.00% of the stock of Semler Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions58.94% of the stock of Semler Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Semler Scientific is 13.72, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 129.71.Price to Earnings Ratio vs. SectorThe P/E ratio of Semler Scientific is 13.72, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 93.40.Price to Book Value per Share RatioSemler Scientific has a P/B Ratio of 3.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Semler Scientific (OTCMKTS:SMLR) StockSemler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers' patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.Read More Receive SMLR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address SMLR Stock News HeadlinesMay 29, 2023 | finance.yahoo.comWith 45% ownership, Semler Scientific, Inc. (NASDAQ:SMLR) has piqued the interest of institutional investorsMay 14, 2023 | americanbankingnews.comSemler Scientific (OTCMKTS:SMLR) Stock Passes Below Two Hundred Day Moving Average of $29.15May 30, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>May 11, 2023 | finanznachrichten.deSemler Scientific, Inc.: Semler Scientific Reports First Quarter 2023 Financial ResultsMay 10, 2023 | msn.comSemler Scientific: Q1 Earnings InsightsMay 10, 2023 | finance.yahoo.comSemler Scientific Reports First Quarter 2023 Financial ResultsMay 9, 2023 | markets.businessinsider.comHere's what Wall Street expects from Semler Scientific's earningsMay 9, 2023 | benzinga.comA Preview Of Semler Scientific's EarningsMay 30, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>May 1, 2023 | finance.yahoo.comSemler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023April 28, 2023 | msn.comDoug Murphy-Chutorian becomes interim CEO of Semler ScientificApril 28, 2023 | finance.yahoo.comSemler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEOApril 28, 2023 | americanbankingnews.comCritical Survey: Semler Scientific (OTCMKTS:SMLR) and CONMED (NYSE:CNMD)April 27, 2023 | uk.finance.yahoo.comInvestors in Semler Scientific (NASDAQ:SMLR) have seen strong returns of 183% over the past five yearsApril 19, 2023 | finance.yahoo.comSemler Scientific Announces Appointment of Eric Semler and William Chang as DirectorsApril 7, 2023 | finance.yahoo.comShould You Hold Semler Scientific (SMLR)?April 7, 2023 | finance.yahoo.comIs It Time To Consider Buying Semler Scientific, Inc. (NASDAQ:SMLR)?April 5, 2023 | finance.yahoo.comSemler Scientific to Participate in the 22nd Annual Needham Virtual Healthcare ConferenceMarch 24, 2023 | finance.yahoo.comSemler Scientific, Inc. (NASDAQ:SMLR) Q4 2022 Earnings Call TranscriptMarch 22, 2023 | benzinga.comSemler Scientific shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.March 21, 2023 | marketwatch.comSemler Scientific Chief Executive Murphy-Chutorian to Step DownMarch 21, 2023 | msn.comSemler Scientific named Wayne Pan new CEOMarch 21, 2023 | finance.yahoo.comSemler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO Effective April 3, 2023March 21, 2023 | finance.yahoo.comSemler Scientific Reports Fourth Quarter and Full Year 2022 Financial ResultsMarch 21, 2023 | finance.yahoo.comSemler Scientific, Inc.'s (NASDAQ:SMLR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?March 10, 2023 | finance.yahoo.comSemler to Report Fourth Quarter and Year End 2022 Financial Results and Host Conference Call on March 21, 2023March 1, 2023 | finance.yahoo.comSemler Announces Clinical Study Published Using QuantaFlo® as an Aid for Diagnosis of Heart Dysfunction in the Primary Care SettingSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SMLR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address SMLR Company Calendar Last Earnings3/21/2023Today5/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:SMLR Previous SymbolNASDAQ:SMLR CUSIPN/A CIK1554859 Webwww.semlerscientific.com Phone(877) 774-4211FaxN/AEmployees124Year Founded2013Price Target and Rating Average Stock Price Forecast$45.00 High Stock Price Forecast$45.00 Low Stock Price Forecast$45.00 Forecasted Upside/Downside+63.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$2.01 Trailing P/E Ratio13.72 Forward P/E RatioN/A P/E GrowthN/ANet Income$14.32 million Net Margins26.17% Pretax Margin33.48% Return on Equity28.98% Return on Assets25.34% Debt Debt-to-Equity RatioN/A Current Ratio6.23 Quick Ratio6.18 Sales & Book Value Annual Sales$56.69 million Price / Sales3.33 Cash Flow$2.14 per share Price / Cash Flow12.86 Book Value$8.14 per share Price / Book3.39Miscellaneous Outstanding Shares6,850,000Free Float5,961,000Market Cap$188.92 million OptionableNot Optionable Beta0.83 Social Links Key ExecutivesDouglas R. Murphy-ChutorianPresident, CEO, Secretary & DirectorJim KermodeSenior Vice President- OperationsAndrew B. WeinsteinSenior Vice President-Finance & AccountingShane ReidVice President-TechnologyJennifer Oliva HerringtonChief Revenue OfficerKey CompetitorsStereotaxisNYSEAMERICAN:STXSViewRayNASDAQ:VRAYFONARNASDAQ:FONRBioSig TechnologiesNASDAQ:BSGMElectromedNYSE:ELMDView All CompetitorsInstitutional OwnershipEmpower Advisory Group LLCBought 44,867 shares on 5/25/2023Ownership: 0.655%Legato Capital Management LLCBought 8,295 shares on 5/25/2023Ownership: 0.121%Ameriprise Financial Inc.Bought 11,732 shares on 5/22/2023Ownership: 0.492%JPMorgan Chase & Co.Bought 1,974 shares on 5/18/2023Ownership: 0.029%Advisory Services Network LLCSold 1,913 shares on 5/17/2023Ownership: 0.143%View All Institutional Transactions SMLR Stock - Frequently Asked Questions Should I buy or sell Semler Scientific stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Semler Scientific in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SMLR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SMLR, but not buy additional shares or sell existing shares. View SMLR analyst ratings or view top-rated stocks. What is Semler Scientific's stock price forecast for 2023? 1 brokerages have issued 1-year target prices for Semler Scientific's stock. Their SMLR share price forecasts range from $45.00 to $45.00. On average, they predict the company's share price to reach $45.00 in the next year. This suggests a possible upside of 63.2% from the stock's current price. View analysts price targets for SMLR or view top-rated stocks among Wall Street analysts. How have SMLR shares performed in 2023? Semler Scientific's stock was trading at $33.00 at the beginning of the year. Since then, SMLR stock has decreased by 16.4% and is now trading at $27.58. View the best growth stocks for 2023 here. How were Semler Scientific's earnings last quarter? Semler Scientific, Inc. (OTCMKTS:SMLR) released its earnings results on Tuesday, March, 21st. The medical equipment provider reported $0.41 earnings per share for the quarter. The medical equipment provider had revenue of $13.79 million for the quarter. Semler Scientific had a net margin of 26.17% and a trailing twelve-month return on equity of 28.98%. What ETFs hold Semler Scientific's stock? ETFs with the largest weight of Semler Scientific (OTCMKTS:SMLR) stock in their portfolio include Janus Henderson Small Cap Growth Alpha ETF (JSML), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), What guidance has Semler Scientific issued on next quarter's earnings? Semler Scientific issued an update on its first quarter 2023 earnings guidance on Wednesday, March, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $17.40 million-$17.80 million, compared to the consensus revenue estimate of $15.30 million. What other stocks do shareholders of Semler Scientific own? Based on aggregate information from My MarketBeat watchlists, some companies that other Semler Scientific investors own include BioSpecifics Technologies (BSTC), Anavex Life Sciences (AVXL), Cornerstone OnDemand (CSOD), Innoviva (INVA), Novo Nordisk A/S (NVO), Sorrento Therapeutics (SRNE), Vertex Pharmaceuticals (VRTX), Acer Therapeutics (ACER), Allena Pharmaceuticals (ALNA) and Digital Turbine (APPS). What is Semler Scientific's stock symbol? Semler Scientific trades on the OTCMKTS under the ticker symbol "SMLR." Who are Semler Scientific's major shareholders? Semler Scientific's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Punch & Associates Investment Management Inc. (2.27%), Avalon Investment & Advisory (1.94%), Rice Hall James & Associates LLC (1.36%), Acadian Asset Management LLC (1.16%), BlackRock Inc. (1.14%) and Empower Advisory Group LLC (0.65%). Insiders that own company stock include Douglas Murphy-Chutorian, HC Chang & Diana Sho William and Wayne T Pan. View institutional ownership trends. How do I buy shares of Semler Scientific? Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Semler Scientific's stock price today? One share of SMLR stock can currently be purchased for approximately $27.58. How much money does Semler Scientific make? Semler Scientific (OTCMKTS:SMLR) has a market capitalization of $188.92 million and generates $56.69 million in revenue each year. The medical equipment provider earns $14.32 million in net income (profit) each year or $2.01 on an earnings per share basis. How many employees does Semler Scientific have? The company employs 124 workers across the globe. How can I contact Semler Scientific? Semler Scientific's mailing address is 911 BERN COURT SUITE 110, SAN JOSE CA, 95112. The official website for the company is www.semlerscientific.com. The medical equipment provider can be reached via phone at (877) 774-4211 or via email at susan@sanoonan.com. This page (OTCMKTS:SMLR) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.